Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.
Cuervas-Mons V, Herrero JI, Gomez MA, González-Pinto I, Serrano T, de la Mata M, Fabregat J, Gastaca M, Bilbao I, Varo E, Sánchez-Antolín G, Rodrigo J, Espinosa MD. Cuervas-Mons V, et al. Among authors: fabregat j. Clin Transplant. 2015 Aug;29(8):667-77. doi: 10.1111/ctr.12557. Epub 2015 Jun 29. Clin Transplant. 2015. PMID: 25924549 Clinical Trial.
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Lladó L, Xiol X, Figueras J, Ramos E, Memba R, Serrano T, Torras J, Garcia-Gil A, Gonzalez-Pinto I, Castellote J, Baliellas C, Fabregat J, Rafecas A; Thosin Study Group. Lladó L, et al. Among authors: fabregat j. J Hepatol. 2006 Apr;44(4):710-6. doi: 10.1016/j.jhep.2005.12.010. Epub 2006 Jan 24. J Hepatol. 2006. PMID: 16487622 Clinical Trial.
Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study.
Lladó L, Fabregat J, Castellote J, Ramos E, Xiol X, Torras J, Serrano T, Baliellas C, Figueras J, Garcia-Gil A, Rafecas A; THOSIN Study Group. Lladó L, et al. Among authors: fabregat j. Liver Transpl. 2008 Dec;14(12):1752-60. doi: 10.1002/lt.21629. Liver Transpl. 2008. PMID: 19025919 Free article. Clinical Trial.
Liver retransplantation in HIV-infected patients: a prospective cohort study.
Gastaca M, Aguero F, Rimola A, Montejo M, Miralles P, Lozano R, Castells L, Abradelo M, Mata Mde L, San Juan Rodríguez F, Cordero E, Campo Sd, Manzardo C, de Urbina JO, Pérez I, Rosa Gde L, Miro JM; FIPSE OLT-HIV investigators. Gastaca M, et al. Am J Transplant. 2012 Sep;12(9):2465-76. doi: 10.1111/j.1600-6143.2012.04142.x. Epub 2012 Jun 15. Am J Transplant. 2012. PMID: 22703615 Free article.
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.
Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Dong G, Lopez PM, Fung J, Junge G; H2304 Study Group. Saliba F, et al. Am J Transplant. 2013 Jul;13(7):1734-45. doi: 10.1111/ajt.12280. Epub 2013 May 28. Am J Transplant. 2013. PMID: 23714399 Free article. Clinical Trial.
226 results